Shivalik Rasayan Ltd (IN:SHIVALIK)
:SHIVALIK
Want to see IN:SHIVALIK full AI Analyst Report?
Top Page
Shivalik Rasayan Ltd
(SHIVALIK)
Select Model
Select Model
Rating:58Neutral
Price Target:
₹304.00
▼(-15.26% Downside)
Action:Reiterated
Date:05/30/26
The score is primarily held back by weak cash conversion (negative operating and free cash flow) and softer profitability, despite steady revenue growth and a relatively strong, low-leverage balance sheet. Technical signals are modestly supportive, but a high P/E and very low dividend yield reduce the valuation contribution.
Positive Factors
Steady revenue growth
Consistent top-line expansion across 2021–2026 indicates resilient end-market demand and growing customer traction. Durable revenue growth supports scale, capacity utilization and long-term investments, providing a foundation for margin recovery if profitability drivers are restored.
Negative Factors
Weak cash generation
Persistent negative operating and free cash flow points to working-capital pressure and weak cash conversion. Over months this increases reliance on reserves or external financing, constrains reinvestment, and risks underfunding growth or maintenance capex.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady revenue growth
Consistent top-line expansion across 2021–2026 indicates resilient end-market demand and growing customer traction. Durable revenue growth supports scale, capacity utilization and long-term investments, providing a foundation for margin recovery if profitability drivers are restored.
Read all positive factors
Shivalik Rasayan Ltd (SHIVALIK) vs. iShares MSCI India ETF (INDA)
Market Cap
₹4.60B
Dividend Yield0.13%
Average Volume (3M)1.25K
Price to Earnings (P/E)39.1
Beta (1Y)1.01
Revenue Growth18.04%
EPS Growth-30.39%
CountryIN
Employees267
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)9.00
Shares Outstanding15,750,365
10 Day Avg. Volume987
30 Day Avg. Volume1,247
Financial Highlights & Ratios
PEG Ratio-1.05
Price to Book (P/B)0.58
Price to Sales (P/S)0.94
P/FCF Ratio-5.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Shivalik Rasayan Ltd Business Overview & Revenue Model
Company Description
Shivalik Rasayan Ltd. engages in the manufacture of pharmaceutical and agrochemical products. Its products include organophosphorous based insecticides and chemicals. The company was founded by Rahul Bishnoi on March 16, 1979 and is headquartered ...
How the Company Makes Money
The company primarily makes money by manufacturing and selling chemical products (including APIs, intermediates, and other specialty/fine chemicals) to customers, generating revenue from product sales. Its earnings are driven by volumes sold and r...
Shivalik Rasayan Ltd Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
78
Positive
Cash Flow
22
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.38B | 3.68B | 3.12B | 2.73B | 2.34B | 2.07B |
| Gross Profit | 1.30B | 1.00B | 805.70M | 1.33B | 1.20B | 533.21M |
| EBITDA | 503.80M | 457.65M | 485.11M | 461.64M | 493.13M | 534.26M |
| Net Income | 140.50M | 121.36M | 166.96M | 127.17M | 212.35M | 256.06M |
Balance Sheet | ||||||
| Total Assets | 8.04B | 8.19B | 7.34B | 6.92B | 5.78B | 4.88B |
| Cash, Cash Equivalents and Short-Term Investments | 468.39M | 343.68M | 279.69M | 377.38M | 306.71M | 707.58M |
| Total Debt | 1.00B | 1.14B | 938.83M | 859.67M | 655.12M | 411.22M |
| Total Liabilities | 2.18B | 2.20B | 1.98B | 1.85B | 1.59B | 1.24B |
| Stockholders Equity | 5.87B | 5.99B | 5.36B | 3.90B | 3.10B | 2.87B |
Cash Flow | ||||||
| Free Cash Flow | -267.77M | -581.61M | -294.37M | -757.31M | -821.81M | -138.32M |
| Operating Cash Flow | -168.43M | -414.68M | -86.05M | -80.75M | -189.49M | 111.34M |
| Investing Cash Flow | -157.64M | -233.18M | -208.31M | -743.08M | -707.72M | -233.56M |
| Financing Cash Flow | 514.76M | 711.84M | 196.69M | 894.49M | 496.34M | 782.07M |
Shivalik Rasayan Ltd Technical Analysis
Positive
358.75
Price Trends
258.52
Positive
283.58
Positive
362.24
Negative
Market Momentum
0.84
Negative
63.97
Neutral
65.80
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SHIVALIK, the sentiment is Positive. The current price of 358.75 is above the 20-day moving average (MA) of 263.66, above the 50-day MA of 258.52, and below the 200-day MA of 362.24, indicating a neutral trend. The MACD of 0.84 indicates Negative momentum. The RSI at 63.97 is Neutral, neither overbought nor oversold. The STOCH value of 65.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:SHIVALIK.
Shivalik Rasayan Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | ₹8.97B | 18.64 | ― | ― | 15.32% | 158.73% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ₹4.59B | 24.09 | ― | 0.82% | 3.24% | 6.11% | |
61 Neutral | ₹4.96B | 19.85 | ― | ― | 17.46% | 101.58% | |
59 Neutral | ₹2.69B | 18.14 | ― | 1.49% | 1.73% | -35.32% | |
58 Neutral | ₹4.60B | 39.08 | ― | 0.13% | 18.04% | -30.39% | |
54 Neutral | ₹2.63B | 19.51 | ― | 0.07% | 15.69% | 18.38% |
* Basic Materials Sector Average
IN:SHIVALIK
Shivalik Rasayan Ltd
292.20
-267.27
-47.77%
IN:BODALCHEM
Bodal Chemicals Limited
71.23
-3.17
-4.26%
IN:DICIND
DIC India Limited
500.40
-142.27
-22.14%
IN:MANORG
Mangalam Organics Ltd
579.40
-0.60
-0.10%
IN:PODDARMENT
Poddar Pigments Limited
253.20
-44.54
-14.96%
IN:SRD
Shankar Lal Rampal Dye-Chem Ltd.
41.05
-16.32
-28.45%
Shivalik Rasayan Ltd Corporate Events
Shivalik Rasayan Publishes Audited Results for Quarter and Year Ended March 31, 2026
May 28, 2026
Shivalik Rasayan Limited announced that its Board of Directors has approved the audited financial results for the quarter and full year ended March 31, 2026, at a meeting held on May 27, 2026. The company has also published these audited financial...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.